205 related articles for article (PubMed ID: 22950997)
1. Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer.
Rosen P; Pfister D; Young D; Petrovics G; Chen Y; Cullen J; Böhm D; Perner S; Dobi A; McLeod DG; Sesterhenn IA; Srivastava S
Urology; 2012 Oct; 80(4):749-53. PubMed ID: 22950997
[TBL] [Abstract][Full Text] [Related]
2. Predicting Prostate Cancer Progression as a Function of ETS-related Gene Status, Race, and Obesity in a Longitudinal Patient Cohort.
Cullen J; Young D; Chen Y; Degon M; Farrell J; Sedarsky J; Baptiste W; Rosen P; Tolstikov V; Kiebish M; Kagan J; Srivastava S; Kuo HC; Moncur JT; Rosner IL; Narain N; Akmaev V; Petrovics G; Dobi A; McLeod DG; Srivastava S; Sesterhenn IA
Eur Urol Focus; 2018 Dec; 4(6):818-824. PubMed ID: 28753864
[TBL] [Abstract][Full Text] [Related]
3. Evidence for molecular differences in prostate cancer between African American and Caucasian men.
Khani F; Mosquera JM; Park K; Blattner M; O'Reilly C; MacDonald TY; Chen Z; Srivastava A; Tewari AK; Barbieri CE; Rubin MA; Robinson BD
Clin Cancer Res; 2014 Sep; 20(18):4925-34. PubMed ID: 25056375
[TBL] [Abstract][Full Text] [Related]
4. Increased association of the ERG oncoprotein expression in advanced stages of prostate cancer in Filipinos.
Raymundo EM; Diwa MH; Lapitan MC; Plaza AB; Sevilleja JE; Srivastava S; Sesterhenn IA
Prostate; 2014 Aug; 74(11):1079-85. PubMed ID: 24909781
[TBL] [Abstract][Full Text] [Related]
5. Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue.
Lu Z; Williamson SR; Carskadon S; Arachchige PD; Dhamdhere G; Schultz DS; Stricker H; Peabody JO; Jeong W; Chitale DA; Bismar TA; Rogers CG; Menon M; Gupta NS; Palanisamy N
Prostate; 2020 Jan; 80(1):38-50. PubMed ID: 31584209
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.
Magi-Galluzzi C; Tsusuki T; Elson P; Simmerman K; LaFargue C; Esgueva R; Klein E; Rubin MA; Zhou M
Prostate; 2011 Apr; 71(5):489-97. PubMed ID: 20878952
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy.
Tosoian JJ; Almutairi F; Morais CL; Glavaris S; Hicks J; Sundi D; Humphreys E; Han M; De Marzo AM; Ross AE; Tomlins SA; Schaeffer EM; Trock BJ; Lotan TL
Eur Urol; 2017 May; 71(5):697-700. PubMed ID: 27477529
[TBL] [Abstract][Full Text] [Related]
8. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
Furusato B; Tan SH; Young D; Dobi A; Sun C; Mohamed AA; Thangapazham R; Chen Y; McMaster G; Sreenath T; Petrovics G; McLeod DG; Srivastava S; Sesterhenn IA
Prostate Cancer Prostatic Dis; 2010 Sep; 13(3):228-37. PubMed ID: 20585344
[TBL] [Abstract][Full Text] [Related]
9. Low Frequency of the ERG Oncogene Alterations in Prostate Cancer Patients from India.
Rawal S; Young D; Williams M; Colombo M; Krishnappa R; Petrovics G; McLeod DG; Srivastava S; Sesterhenn IA
J Cancer; 2013; 4(6):468-72. PubMed ID: 23901346
[TBL] [Abstract][Full Text] [Related]
10. Predominance of ERG-negative high-grade prostate cancers in African American men.
Farrell J; Young D; Chen Y; Cullen J; Rosner IL; Kagan J; Srivastava S; McLEOD DG; Sesterhenn IA; Srivastava S; Petrovics G
Mol Clin Oncol; 2014 Nov; 2(6):982-986. PubMed ID: 25279185
[TBL] [Abstract][Full Text] [Related]
11. Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.
Yamoah K; Johnson MH; Choeurng V; Faisal FA; Yousefi K; Haddad Z; Ross AE; Alshalafa M; Den R; Lal P; Feldman M; Dicker AP; Klein EA; Davicioni E; Rebbeck TR; Schaeffer EM
J Clin Oncol; 2015 Sep; 33(25):2789-96. PubMed ID: 26195723
[TBL] [Abstract][Full Text] [Related]
12. TMPRSS2-ERG fusion impacts anterior tumor location in men with prostate cancer.
Yamoah K; Lal P; Awasthi S; Naghavi AO; Rounbehler RJ; Gerke T; Berglund AE; Pow-Sang JM; Schaeffer EM; Dhillon J; Park JY; Rebbeck TR
Prostate; 2021 Feb; 81(2):109-117. PubMed ID: 33141952
[TBL] [Abstract][Full Text] [Related]
13. Racial Variations in Prostate Cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract][Full Text] [Related]
14. A novel genomic alteration of LSAMP associates with aggressive prostate cancer in African American men.
Petrovics G; Li H; Stümpel T; Tan SH; Young D; Katta S; Li Q; Ying K; Klocke B; Ravindranath L; Kohaar I; Chen Y; Ribli D; Grote K; Zou H; Cheng J; Dalgard CL; Zhang S; Csabai I; Kagan J; Takeda D; Loda M; Srivastava S; Scherf M; Seifert M; Gaiser T; McLeod DG; Szallasi Z; Ebner R; Werner T; Sesterhenn IA; Freedman M; Dobi A; Srivastava S
EBioMedicine; 2015 Dec; 2(12):1957-64. PubMed ID: 26844274
[TBL] [Abstract][Full Text] [Related]
15. Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
Farrell J; Petrovics G; McLeod DG; Srivastava S
Int J Mol Sci; 2013 Jul; 14(8):15510-31. PubMed ID: 23892597
[TBL] [Abstract][Full Text] [Related]
16. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY
Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
Cullen J; Lynch JA; Klein EA; Van Den Eeden SK; Carroll PR; Mohler JL; Knezevic D; Farrington TA; Lu R
J Urol; 2021 Apr; 205(4):1047-1054. PubMed ID: 33493001
[TBL] [Abstract][Full Text] [Related]
18. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
[TBL] [Abstract][Full Text] [Related]
19. Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients.
Kimura T; Furusato B; Miki J; Yamamoto T; Hayashi N; Takahashi H; Kamata Y; van Leenders GJ; Visakorpi T; Egawa S
Pathol Int; 2012 Nov; 62(11):742-8. PubMed ID: 23121605
[TBL] [Abstract][Full Text] [Related]
20. ERG expression and prostatic adenocarcinoma.
Verdu M; Trias I; Roman R; Rodon N; Garcia-Pelaez B; Calvo M; Dominguez A; Banus JM; Puig X
Virchows Arch; 2013 Jun; 462(6):639-44. PubMed ID: 23703293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
